Healthcare Pharmaceutical Biotech

Shed GLP-1 Review 2026 Explores Updated Guarantee, Foundayo Approval, Dose-Escalation Pricing, and Key Buyer Questions

June 16, 2026 2:10 PM

ShedRx: Shed GLP-1 Research 2026: Updated Guarantee, Foundayo Approval, the FDA's June 29 Compounding Deadline, and What to Verify Before Enrolling Advertorial Disclosure: This is promotional content with affiliate links - if you enroll through a link in this article, a commission may be earned at no extra cost to you, per FTC 16 CFR Part 255. That relationship doesn't change what's written here. Shed is a telehealth platform; licensed...

Read more

RightWell GLP-1 Review 2026: Is the $159 Compounded GLP-1 Program With a 10% Guarantee Worth It?

June 16, 2026 2:05 PM

Advertorial | Telehealth Platform Disclosure: RightWell is a technology platform operated by Prescribey, Inc. It doesn't practice medicine, employ clinicians, or prescribe medication. All prescribing is performed independently by a licensed medical practice (the "Practice") whose licensed providers make every clinical decision. Compounded medications are prepared and dispensed by certified U.S.-licensed pharmacy partners - separate entities from...

Read more

HonorBridge Names Joel Baucom Chief Operating Officer

June 16, 2026 10:00 AM

HonorBridge is pleased to announce that Joel Baucom, M.Div., has been named Chief Operating Officer. Baucom brings 15 years of experience at HonorBridge to the role, having served in a variety of positions across the organization, including Family Support Coordinator, Manager of Family Services, Director of Organ Operations and Director of Partner Engagement. Baucom earned a Master of Divinity from Campbell University Divinity School and a...

Read more

Medical Care Technologies (OTC PINK:MDCE) Discusses Enterprise-Grade Privacy Architecture for MDCE Melanoma Scan Beta

June 16, 2026 9:11 AM

Medical Care Technologies, Inc. (OTC PINK:MDCE) ("MDCE" or the "Company"), a technology company focused on artificial intelligence, imaging technologies, and digital wellness platforms, today provided an update on the privacy-focused architecture being incorporated into its MDCE Melanoma Scan Beta platform. The MDCE Melanoma Scan Beta platform is being developed as an AI-assisted imaging and skin wellness pre-screening technology designed to...

Read more

SoCal Aesthetic Surgery Expands Treatment Options With Addition of CO₂ SmartXide PRO Laser

June 16, 2026 9:00 AM

SoCal Aesthetic Surgery has expanded its non-surgical skin rejuvenation services with the addition of the CO₂ SmartXide PRO laser, a next-generation fractional resurfacing platform designed to improve skin quality with enhanced precision, customizable treatment settings, and minimal downtime. The practice, led by facial aesthetics specialist Dr. Homer Hojjat, continues to broaden treatment options for patients seeking effective solutions for sun...

Read more

MIB Agents' Community of Families Has Awarded $2.9M in Grants to Research Pediatric Bone Cancer

June 16, 2026 9:00 AM

MIB Agents, a leading pediatric osteosarcoma nonprofit dedicated to Making It Better for its community of patients, caregivers, doctors, and researchers, announced today that since its inception in 2016, it has awarded $2.9 million to scientists across the country through its OutSmarting Osteosarcoma grant program. The OutSmarting Osteosarcoma grants are supported by MIB Agents Family Funds, osteosarcoma patients and families who raise research...

Read more

Barefoot Risks: Why Summer Activities Can Lead to Hidden Foot Injuries, According to Ankle & Foot Centers of America

June 16, 2026 9:00 AM

As temperatures rise and more people spend time outdoors, Ankle & Foot Centers of America is encouraging individuals to be mindful of the hidden risks that summer activities can pose to foot health. Whether walking barefoot at the beach, around the pool, or during outdoor recreation, feet are exposed to a variety of hazards including cuts, puncture wounds, burns from hot surfaces, and infections. Increased activity levels during the summer can...

Read more

Poverty's Toll on Health Outcomes: What Little Rock's Own Data Reveals

June 16, 2026 9:00 AM

Arkansas's most populous county sits at the center of a healthcare paradox. Pulaski County is home to UAMS Medical Center, Baptist Health, and Arkansas Children's Hospital - over 3,000 physicians and 8,000 nurses serving a population of roughly 400,000. Yet the county's health outcomes tell a different story, one shaped less by clinical capacity than by the concentrated, compounding force of poverty. A review of publicly available data from the...

Read more

Aetna Donates $130,000 to Kansas City Organizations To Support Nutrition, Mental Health, Maternal Health and Health-Related Social Needs

June 16, 2026 9:00 AM

Originally published on CVS Health Company Newsroom Aetna Better Health of Missouri, a CVS Health company (NYSE:CVS), announced new collaborations with five local community-based organizations to support better health outcomes in the Kansas City area. Through donations totaling $130,000, Aetna is helping fund initiatives that address nutrition, mental health, maternal health and health-related social needs, reinforcing its commitment to building...

Read more

SpendMend Names Trey Cook as Chief Executive Officer

June 16, 2026 8:30 AM

SpendMend, the leading provider of cost cycle management solutions to the healthcare industry, announced today the appointment of Trey Cook as Chief Executive Officer. Cook succeeds founder Dan Geelhoed, who has served as CEO since founding the company in 1992. Cook brings more than two decades of experience leading high-growth healthcare technology organizations. Most recently, he served as President and CEO of STARLIMS and previously held the...

Read more

TRNR to Report Second Quarter 2026 Results on August 14, 2026; Expects Record Quarterly Revenue of Approximately $8 Million

June 16, 2026 8:30 AM

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the Wattbike, CLMBR, FORME and Ergatta brands, today announced that it will report financial results for its second quarter ended June 30, 2026 on Thursday, August 14, 2026. This will be the first quarter TRNR will report fully consolidated Ergatta results and the Company expects to report record quarterly revenue and...

Read more

Black Book Study Finds Europe is Connected, But Not Yet Interoperable: Only 13% of Healthcare IT Users Say Vendors are EHDS-Ready

June 16, 2026 8:20 AM

Black Book Market Research today announced the availability of its new report, "2026 Europe Health Information System Interoperability, Connectivity & Connected Care Top Performers," available today to European healthcare IT stakeholders at https://blackbookmarketresearch.com/european-ehr-epr-interoperability-and-connected-care-top-performers-2026 The report follows the recent Brussels EHDS interoperability meeting, where European health data...

Read more

Moderna Announces Organizational Changes to Prepare for Multiple Product Launches in 2027 and 2028

June 16, 2026 7:30 AM

Moderna, Inc. (NASDAQ:MRNA) today announced changes to its operating model to support its short- and long-term business goals. As Moderna executes its long-range plan to become a diversified, multi-modality biotechnology company, the Company is preparing to manage three commercial franchises while advancing a broad mRNA pipeline and investing in Moderna research and early development (mRED). Building on strong momentum in its infectious disease...

Read more

Cannabis Industry Attorney Concedes D.C. Circuit Challenge Could Reverse Marijuana Rescheduling

June 16, 2026 6:00 AM

MMJ International Holdings today highlighted a significant development in the ongoing legal challenge to the federal government's marijuana rescheduling order after cannabis industry attorney Jason Adelstone publicly acknowledged that the D.C. Circuit challenge brought by MMJ International Holdings and the National Drug and Alcohol Screening Association (NDASA) presents a substantial threat to the Schedule III rule. In a June 15 analysis...

Read more

Positive Results From The Phase Ib Clinical Study of NeuroRestore ACD856, Under Development for Alzheimer's

June 16, 2026 4:45 AM

AlzeCure Pharma AB (publ) (STO:ALZCUR)(FRA:AC6), a biotech company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that the Phase Ib clinical study of ACD856, the lead drug candidate in the NeuroRestore platform being developed for Alzheimer's disease and other indications, has been completed on schedule with positive results. "Consistent with previous clinical...

Read more

Teknova Expands Digital Publication Experience with Bioz Content Hub Integration

June 16, 2026 4:00 AM

Bioz, Inc., an innovative platform focused on extracting and syndicating insights from scientific publications, announced its continued collaboration with Teknova, a leading manufacturer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Building on a long-standing collaboration, Teknova has expanded its use of Bioz Badges by implementing a fully customized Bioz...

Read more

IRLAB Presents Integrated Analysis of Mesdopetam Data at International Conference - Confirms Robust Efficacy Results in the Phase II Studies

June 16, 2026 1:15 AM

IRLAB Therapeutics AB ((STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for Parkinson's disease, today announces that an integrated analysis of clinical data for mesdopetam, IRLAB's most advanced drug candidate in development to treat levodopa-induced dyskinesia, will be presented at StanCon 2026 in Uppsala in August. The analysis confirms mesdopetam's anti-dyskinetic effect across a broad range of statistical...

Read more

Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2026

June 15, 2026 5:00 PM

Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm today announced that revenues for the three and six months ended April 30, 2026 were approximately $2.7 million and $5.0 million, respectively, representing increases of approximately $0.3 million and $0.1 million compared to the same periods last year. Net income for the three and six months...

Read more

"Three Women and Me" Launches a Bold New Health Media Platform Designed to Change the Conversation Around Women's Health and the Issues Families Face Every Day

June 15, 2026 2:45 PM

At a time when millions of women are searching for answers, navigating complex health challenges, and often feeling unheard, a groundbreaking new television talk show and podcast is preparing to transform the way health conversations happen. Three Women and Me is not just another talk show. It is a bold new media platform created to tackle the questions that affect women, families, relationships, and communities every day, but are too often...

Read more

Harvard Neuroscientist Warns Federal Court: Marijuana Rescheduling May Carry "Unacceptably High" Public Health Risks

June 15, 2026 11:00 AM

As the U.S. Court of Appeals for the D.C. Circuit weighs an emergency motion to stay the federal government's recent marijuana rescheduling order, a newly filed declaration from a Harvard Medical School professor warns that the policy change poses "substantial" and "unacceptably high" risks to public health-particularly for adolescents and unborn children. The declaration (Exhibit D), filed June 9 by Bertha K. Madras, Ph.D. , a Professor of...

Read more